Prostate-MRI-US-Biopsy
Prostate MRI and Ultrasound With Pathology and Coordinates of Tracked Biopsy
3D transrectal ultrasound of 1,151 men having MRI-ultrasound fusion prostate biopsy at UCLA, with T2-weighted and diffusion MRI for most, prostate and target surfaces, tracked biopsy core coordinates and Gleason grades per core.
Overview
Prostate-MRI-US-Biopsy comes from tracked prostate biopsy sessions at the UCLA Clark Urology Center, performed with the Artemis system. In most sessions, a 3D transrectal ultrasound volume was fused nonrigidly with a prior MRI so that cores could be aimed at MRI-defined targets, and most sessions also took systematic cores from a 12-core template. The system logged where every core was taken. The Cancer Imaging Archive released the collection in 2020 and added diffusion MRI in version 2 in 2023. It suits prostate segmentation, MRI-ultrasound registration, lesion detection and prediction of biopsy pathology.
Composition
Version 2 holds 1,151 men with 2,799 studies, 4,819 DICOM series and 102,397 images (80.21 GB). Every patient has ultrasound; 842 also have MRI. Version 1 contained T2-weighted MRI only, and version 2 added ADC maps and high b-value diffusion images (mostly a calculated b of 1400) for 837 patients. Patients were enrolled consecutively when PSA or imaging raised suspicion of prostate cancer and they had a standard-of-care biopsy planned. In the manifest, ages at the first MRI study range from 45 upward, with a median of 65.
Acquisition
Most MRI was acquired at 3 T on Siemens Trio, Verio or Skyra scanners with a pelvic phased-array coil, in some cases with an endorectal coil. The usual T2-weighted sequence is a 3D SPACE scan with 1.5 mm slice spacing; some cases used 3D TSE, and a few studies were imported from other institutions with other protocols. Ultrasound used a Hitachi Hi-Vision 5500 or Noblus end-fire probe rotated through 200 degrees and resampled to an isotropic volume.
Annotations
STL surfaces give the prostate gland, segmented semi-automatically on MRI and ultrasound, and radiologist-drawn MRI targets, transferred to ultrasound by registration. A spreadsheet scores each target on a 1 to 5 suspicion scale close to PI-RADS v2 and lists its volume. A second spreadsheet lists every core with ultrasound and, for about 70%, MRI coordinates, primary and secondary Gleason grade, cancer core length, PSA and prostate volume. 3D Slicer overlay files combine surfaces and core paths.
Known limitations
- Ultrasound targets carry registration error of about 3 to 4 mm.
- MRI coordinates and MRI links are missing for about 30% of cores, and tissue length for about 40%.
- Perfusion-weighted MRI, used when targets were read, is not included.
- Some ADC maps were recomputed offline, and some private DICOM tags may be altered.
Cohort
Aggregate numbers from the sources below. Bars are relative to the 1,151 subjects.
Sex
- Male 1,151 100%
Age
mean 65.4± 7.5Modality
subjects
- Ultrasound 1,151 100%
- MRI 842 73%
Contrast / sequence
subjects, values can overlap
- ADC map 837 73%
- Diffusion-weighted 837 73%
Scanner vendor
subjects
- Eigen 1,151 100%
- Siemens Healthineers 808 70%
- GE HealthCare 26 2%
- Philips 9 <1%
License and access
Our reading of the license, not legal advice. Before you use the data, read the original license and confirm that your use is allowed. We take no responsibility for how you use a dataset. Full disclaimer
Download without an account
DICOM images download with the TCIA Data Retriever or through the Imaging Data Commons. Biopsy and target spreadsheets are direct downloads; STL surfaces and 3D Slicer biopsy overlays are Aspera downloads.
Creative Commons Attribution 4.0 International
Use, share and adapt the data for any purpose, including commercial use, as long as you credit the creators.
What you can do
- Yes
- Yes
- Yes
- Yes
What you can share
- Yes
- Yes
- Yes
What you must do
- Yes
- Share alike No
- No
- No
- Manuscript review No
- Release code No
- Return results No
- Delete after use No
Limits
- No
- Location limits No
Citation
Natarajan, S., Priester, A., Margolis, D., Huang, J., & Marks, L. (2020). Prostate MRI and Ultrasound With Pathology and Coordinates of Tracked Biopsy (Prostate-MRI-US-Biopsy) (version 2) [Data set]. The Cancer Imaging Archive. https://doi.org/10.7937/TCIA.2020.A61IOC1A
All numbers
Every number on this page, as stored in stats.csv, with its source.
| Measure | Breakdown | Value | Source |
|---|---|---|---|
| Subjects | total Images row | 1,151 | tcia-prostate-mri-us-biopsy Data Access table |
| Studies | total Images row | 2,799 | tcia-prostate-mri-us-biopsy Data Access table |
| Scans | total DICOM series, MR and US | 4,819 | tcia-prostate-mri-us-biopsy Data Access table |
| Images | total DICOM images; each US series is one multi-frame image | 102,397 | tcia-prostate-mri-us-biopsy Data Access table |
| Subjects | contrast=ADC added in version 2 | 837 | tcia-prostate-mri-us-biopsy Diffusion-MRI-Supplement-To-Prostate-MRI-US-Biopsy |
| Subjects | contrast=dwi high b-value DWI, mostly calculated b=1400; added in version 2 | 837 | tcia-prostate-mri-us-biopsy Diffusion-MRI-Supplement-To-Prostate-MRI-US-Biopsy |
| Subjects | modality=US | 1,151 | tcia-prostate-mri-us-biopsy-digest Patient ID, Modality |
| Subjects | modality=MR | 842 | tcia-prostate-mri-us-biopsy-digest Patient ID, Modality |
| Scans | modality=US | 1,762 | tcia-prostate-mri-us-biopsy-digest Series Instance UID, Modality |
| Scans | modality=MR | 3,057 | tcia-prostate-mri-us-biopsy-digest Series Instance UID, Modality |
| Subjects | sex=male | 1,151 | tcia-prostate-mri-us-biopsy-digest Patient ID, Patient Sex |
| Subjects | vendor=eigen Artemis ultrasound series | 1,151 | tcia-prostate-mri-us-biopsy-digest Patient ID, Manufacturer |
| Subjects | vendor=siemens MR | 808 | tcia-prostate-mri-us-biopsy-digest Patient ID, Manufacturer |
| Subjects | vendor=ge MR from other institutions | 26 | tcia-prostate-mri-us-biopsy-digest Patient ID, Manufacturer |
| Subjects | vendor=philips MR from other institutions | 9 | tcia-prostate-mri-us-biopsy-digest Patient ID, Manufacturer |
| Subjects | age=40-49 age at the first study with an age; 839 subjects have one | 17 | tcia-prostate-mri-us-biopsy-digest Patient ID, Patient Age, Study Date |
| Subjects | age=50-59 age at the first study with an age | 166 | tcia-prostate-mri-us-biopsy-digest Patient ID, Patient Age, Study Date |
| Subjects | age=60-69 age at the first study with an age | 402 | tcia-prostate-mri-us-biopsy-digest Patient ID, Patient Age, Study Date |
| Subjects | age=70-79 age at the first study with an age | 233 | tcia-prostate-mri-us-biopsy-digest Patient ID, Patient Age, Study Date |
| Subjects | age=80+ age at the first study with an age | 21 | tcia-prostate-mri-us-biopsy-digest Patient ID, Patient Age, Study Date |
| Mean age | total 839 subjects with an age | 65.4 | tcia-prostate-mri-us-biopsy-digest Patient ID, Patient Age, Study Date |
| Age SD | total 839 subjects with an age | 7.5 | tcia-prostate-mri-us-biopsy-digest Patient ID, Patient Age, Study Date |
| Median age | total 839 subjects with an age | 65 | tcia-prostate-mri-us-biopsy-digest Patient ID, Patient Age, Study Date |
| Minimum age | total 839 subjects with an age | 45 | tcia-prostate-mri-us-biopsy-digest Patient ID, Patient Age, Study Date |
Sources
The keys used in the table above.
- tcia-prostate-mri-us-biopsy TCIA Prostate-MRI-US-Biopsy collection page (version 2, updated 2023/10/20) website
- tcia-prostate-mri-us-biopsy-digest TCIA NBIA manifest digest for version 2 (CC BY 4.0, open download), counted per unique Patient ID computed